✦ LIBER ✦

Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients

✍ Scribed by Jara-Palomares, Luis; Sanchez-Oro-Gomez, Raquel; Elias-Hernandez, Teresa; Morillo-Guerrero, Raquel; Ferrer-Galvan, Marta; Asensio-Cruz, Maria Isabel; Barrot-Cortes, Emilia; Otero-Candelera, Remedios

Book ID: 127000611
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 364 KB
Volume: 134
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2014.06.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of rivaroxaban for short- and lo

The use of rivaroxaban for short- and long-term treatment of venous thromboembolism

✍ Cohen, A. T.; Dobromirski, M. 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 366 KB

Cost-effectiveness of rivaroxaban versus

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective

✍ Seaman, Craig D.; Smith, Kenneth J.; Ragni, Margaret V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 415 KB

RIVAROXABAN FOR THE TREATMENT OF SYMPTOM

RIVAROXABAN FOR THE TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM: IS THERE A NEED FOR INITIAL HEPARIN TREATMENT? A SUBGROUP ANALYSIS OF THE EINSTEIN DVT AND PE STUDIES

✍ Lensing, Anthonie W.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Anticoagulation in the Treatment of Esta

Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer

✍ Lee, A. Y.Y. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 117 KB

Anticoagulation for the initial treatmen

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer : A systematic review

✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology

Oral rivaroxaban versus standard therapy

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

✍ Prins, Martin H; Lensing, Anthonie WA; Bauersachs, Rupert; van Bellen, Bonno; Bo 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 200 KB